<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>The Roslin Institute</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/DEEE828C-6EDF-466F-951F-DC32D639CECE"><gtr:id>DEEE828C-6EDF-466F-951F-DC32D639CECE</gtr:id><gtr:firstName>Ivan</gtr:firstName><gtr:surname>Morrison</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BBS%2FE%2FD%2F05201235"><gtr:id>F8EB282A-F631-4652-B7C5-252835E63315</gtr:id><gtr:title>Mucosal immunity</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>BBS/E/D/05201235</gtr:grantReference><gtr:abstractText>The gut mucosal immune system displays a number of unique features, which pose challenges for induction of immunity against mucosal pathogens. We aim to enhance understanding of the mechanisms employed by pathogens to colonise the gastro-intestinal epithelium and the pathogen-induced changes in the gut epithelium which promote induction of an immune response. The overall aim of this theme is to understand immune processes within the gut mucosa, particularly with respect to pathogens that colonise the mucosal surface. Also, we aim to gain a better understanding of regulatory immune processes that ensure the maintenance of homeostasis in the gut. The work will focus, firstly, on the interaction of the organisms with the gut epithelium in relation to their ability to colonise and to induce immune responses. Secondly, the role of effector immune cells and their interactions with gut epithelial cells in mediating immunity will be investigated. The objectives are: To characterise the immune cell populations of mucosal sites (especially gut and lung) in model organisms and major livestock species. To investigate the factors underlying the tropism of E. coli O157:H7 for the terminal rectum of cattle. To understand the mechanisms by which enteric pathogens modulate immune responses.</gtr:abstractText><gtr:fund><gtr:end>2012-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2008-08-01</gtr:start><gtr:type>EXPENDITURE_PROJECTED</gtr:type><gtr:valuePounds>877959</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Identification of candidate antigens for vaccine development.</gtr:description><gtr:firstYearOfImpact>2011</gtr:firstYearOfImpact><gtr:id>0DA61D00-D112-4F25-964B-8E72CF6CA47F</gtr:id><gtr:impactTypes><gtr:impactType>Policy &amp; public services</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56e03f10323cc8.54501459</gtr:outcomeId><gtr:sector>Agriculture, Food and Drink,Healthcare</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>Studies of calves infected with enterohaemorrhagic Escherichia coli O157 (EHEC O157) have demonstrated that the bacteria selectively colonise M-like cells in the follicle-associated epithelium
of the bovine rectum. An in vitro epithelial cell culture system has been established to facilitate studies of bacterial-host cell interactions. - Based on studies with cultured rectum epithelium, both H7 flagellin and Shiga toxin have been shown to act as colonisation factors for EHEC O157 (Mahajan et al. Cell Microbiol 11, 121-137). H7 flagellin mediates epithelial binding during the initial stages of colonisation. Binding of Shiga toxin
results in upregulation of nucleolin and Annexin II, leading to redistribution of Annexin II to the surface of epithelial cells where it can bind to the bacterial outer-membrane protein intimin and the translocated intimin receptor (Tir) (submitted). - Based on these molecular studies, vaccination of calves with purified H7 alone or in combination with certain type III secretion (T3S) system proteins was shown to protect against EHEC O157 colonisation (McNeilly et al. Infect. Immun. 76:2594-602, McNeilly et al. Vaccine 28:1422-28). This work has led to an internationally filed patent with support from Novartis Animal Health.</gtr:description><gtr:exploitationPathways>Further research</gtr:exploitationPathways><gtr:id>DEEFF4B2-CB12-407D-B5E2-F6849DFD610E</gtr:id><gtr:outcomeId>56e03e44d67993.21827886</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Healthcare</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">BBS/E/D/05201235</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>